Publications
Cancer (190 POSTS)
2015 (6 POSTS)
Inhalation cancer risk assessment of hexavalent chromium based on updated mortality for Painesville chromate production workers
Proctor DM, Suh M, Mittal L, Hirsch S, Salgado RV, Bartlett C, Van Landingham C, Rohr A, Crump K. 2015. Inhalation cancer risk assessment of hexavalent chromium based on updated mortality for Painesville chromate production workers. J Expo Sci Environ Epidemiol 26(2):224-231. doi: 10.1038/jes.2015.77.
View AbstractAcute lymphoblastic leukemia: An assessment of international incidence, survival, and disease burden
Katz AJ, Chia VM, Schoonen WM, Kelsh MA. 2015. Acute lymphoblastic leukemia: An assessment of international incidence, survival, and disease burden. Cancer Causes Control 26(11):1627–1642.
View AbstractLung cancer risk in chromate production workers exposed to hexavalent chromium
Suh M, Mittal L, Hirsch S, Valdes R, Bartlett C, Rohr A, Proctor D. 2015. Lung cancer risk in chromate production workers exposed to hexavalent chromium. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View AbstractInhalation cancer risk assessment of titanium dioxide
Proctor D, Suh M, Thompson C, Hixon, G. Inhalation cancer risk assessment of titanium dioxide. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View AbstractCPX-351 enables administration of consolidation treatment in the outpatient setting and increases the time spent out of the hospital after completion of AML treatment compared with 7+3
Lancet JE, Cyr PL, Sacks NC, Chiarella MT, Louie AC, Cortes JE. CPX-351 enables administration of consolidation treatment in the outpatient setting and increases the time spent out of the hospital after completion of AML treatment compared with 7+3. American Society of Hematology Annual Meeting, San Diego CA, 2015.
Toxicology based cancer causation analysis of COCR-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies
Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. Toxicology based cancer causation analysis of COCR-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. Poster presentation at Society of Toxicology 54th Annual Meeting, San Diego, CA, 2015.
2014 (6 POSTS)
Development of non-cancer based toxicity factors and daily dose estimates for TBBPA
Haws LC, Thompson C, Perry C, White M, Fitzgerald L, Borghoff S, Wikoff D. Development of non-cancer based toxicity factors and daily dose estimates for TBBPA. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.
View AbstractPrognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study
Erichsen R, Kelsh MA, Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.
Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures
Proctor DM, Suh M, Campleman SL, Thompson CM. 2014. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures. Toxicol 325(Nov):160-179; doi: 10.1016/j.tox.2014.08.009.
View AbstractIncreased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis
Jensen IS, Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis. Abstract C14, Academy of Managed Care Pharmacy 26th Annual Meeting & Expo, 2014.
View AbstractDevelopment of an oral cancer slope factor and lifetime average daily dose estimates for TBBPA
Wikoff D, Thompson C, Perry C, White M, Fitzgerald L, Borghoff S, Haws LC. Development of an oral cancer slope factor and lifetime average daily dose estimates for TBBPA. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.
View AbstractA chronic oral reference dose for hexavalent chromium-induced intestinal cancer
Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays S, Hixon JG, Harris MA. 2014. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol 34:525-536. doi: 10.1002/jat.2907.
View Abstract2013 (6 POSTS)
Multiple myeloma risk and benzene exposure among pliofilm workers – A re-analysis using an internal reference group
Lamm SH, Britt JK, James RC. Multiple myeloma risk and benzene exposure among pliofilm workers – A re-analysis using an internal reference group. Presented at Society of Toxicology 52nd Annual Meeting, March 10-14, San Antonio, TX, March 2013.
View AbstractPrevalence and incidence of comorbidities in elderly women with ovarian cancer
Chia VM, O’Malley CD, Danese MD, Lindquist KJ, Gleeson ML, Kelsh MA, et al. 2013. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. Gynecol Oncol 129(2):346–352; doi: 10.1016/j.ygyno.2013.02.014. PMID: 23422502.
View AbstractAn international assessment of ovarian cancer incidence and mortality
Lowe KA, Chia VM, Taylor A, O’Malley C, Kelsh M, Mohamed M, et al. 2013. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 130(1):107–114; doi: 10.1016/j.ygyno.2013.03.026. PMID: 23558050.
View AbstractDevelopment of an oral cancer slope factor for acrylamide based on tumors relevant to humans
Urban JD, Thompson CM, Deskin R, Waite M, Haws LC. 2013. Development of an oral cancer slope factor for acrylamide based on tumors relevant to humans. Presented at Society of Toxicology 52nd Annual Meeting, San Antonio, TX, March 2013.
View AbstractChildhood cancer incidence in Pennsylvania counties in relation to living in counties with hydraulic fracturing sites
Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Childhood cancer incidence in Pennsylvania counties in relation to living in counties with hydraulic fracturing sites. J Occup Environ Med 55(7):796–801; doi: 10.1097/JOM.0b013e318289ee02.
View AbstractMode of action evaluation for hexavalent chromium-induced lung cancer
Proctor DM, Suh M, Thompson CM, Harris MA. 2013. Mode of action evaluation for hexavalent chromium-induced lung cancer. Presented at Society of Toxicology 52nd Annual Meeting, March 10-14, San Antonio, TX.
View Abstract2012 (5 POSTS)
A multisource approach to improving epidemiologic estimates: Application to global B-cell malignancies
Mitchell M, Lowe K, Fryzek J. 2012. A multisource approach to improving epidemiologic estimates: Application to global B-cell malignancies. ISRN Oncol 2012:129713; 10.5402/2012/129713.
View AbstractComorbid conditions in elderly women with and without ovarian cancer
Chia VM, O’Malley CD, Danese M, Lindquist K, Gleesen M, Kelsh MA, et al. Comorbid conditions in elderly women with and without ovarian cancer. Presented at International Gynecological Cancer Society Annual Meetings, Vancouver, Canada, October 13–16, 2012.